-
公开(公告)号:US20080009525A1
公开(公告)日:2008-01-10
申请号:US11888493
申请日:2007-07-31
申请人: Shogo Sakuma , Tomio Yamakawa , Takashi Kanda , Seiichiro Masui
发明人: Shogo Sakuma , Tomio Yamakawa , Takashi Kanda , Seiichiro Masui
IPC分类号: A61K31/4439 , A61K31/422 , C07D263/02 , C07D403/00 , C07D417/00 , C07D413/00 , C07D277/04 , A61K31/427
CPC分类号: C07D263/62 , C07D263/32 , C07D277/24
摘要: A compound represented by the following general formula (I): (wherein R1 represents phenyl, etc. which can have substituents selected from the group consisting of C1-8 alkyl, C1-8 alkyl having halogen, halogen, hydroxyl, etc.; R2 represents C1-8 alkyl, etc.; A represents oxygen, sulfur, etc.; X represents C1-8 alkylene chain, etc.; Y represents C(═O), CH═CH, etc.; R3, R4, and R5 each represents hydrogen, C1-8 alkyl, etc.; B represents CH or nitrogen; Z represents oxygen or sulfur; R6 and R7 each represents hydrogen, C1-8 alkyl, etc.; and R8 represents hydrogen or C1-8 alkyl; provided that at least one of R3, R4, and R5 is not hydrogen) or a salt of the compound; and a PPAR-δ activator which contains the compound or salt as the active ingredient.
摘要翻译: 由以下通式(I)表示的化合物:(其中R 1表示苯基等,其可以具有选自C 1-8烷基的取代基 具有卤素,卤素,羟基等的C 1-8烷基; R 2表示C 1-8烷基等; A 表示氧,硫等; X表示C 1-8亚烷基链等; Y表示C(-O),CH-CH等; R 3 O R 4,R 5和R 5各自表示氢,C 1-8烷基等; B表示CH或氮; Z表示 氧或硫; R 6和R 7各自表示氢,C 1-8烷基等;和R 8, / SUP>表示氢或C 1-8烷基,条件是R 3,R 4和R 4中的至少一个, 5不是氢)或化合物的盐; 和含有该化合物或盐作为活性成分的PPAR-δ活化剂。
-
公开(公告)号:US20070027196A1
公开(公告)日:2007-02-01
申请号:US11544505
申请日:2006-10-06
申请人: Shogo Sakuma , Tomio Yamakawa , Takashi Kanda , Seiichiro Masui
发明人: Shogo Sakuma , Tomio Yamakawa , Takashi Kanda , Seiichiro Masui
IPC分类号: A61K31/427 , A61K31/422 , C07D417/02 , C07D413/02
CPC分类号: C07D403/06 , A61K31/00 , A61K31/423 , A61K31/427 , A61K31/454 , C07D405/06 , C07D409/06 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/06 , C07D417/12 , C07D417/14
摘要: A compound represented by the formula (I) or a salt of the compound, and a PPAR-δ activator which contains the compound or salt as the active ingredient: (wherein A represents O or S; B1 represents N, etc.; B2 represents O, etc.; each of X1 and X2 represents O, S, a bond, etc.; Y represents C1-8 alkylene chain; z represents O or S; R1 represents aryl, etc. which can have substituents; R2 represents C1-8 alkyl, etc.; R3 represents C1-8 alkyl, C2-8 alkenyl, etc.; each of R4 and R5 represents hydrogen, C1-8 alkyl, etc.; and R6 represents hydrogen, etc.; provided that each of Z and R3 is attached to the benzene ring, and X2 is not attached to the benzene ring).
摘要翻译: 由式(I)表示的化合物或化合物的盐和含有该化合物或盐作为活性成分的PPAR-δ活化剂:(其中A表示O或S; B < 表示N等; B 2表示O等; X 1和X 2各自表示O,S,键, Y表示C 1-8亚烷基链; z表示O或S; R 1表示可具有取代基的芳基等; R 2, / SUP表示C 1-8烷基等; R 3表示C 1-8烷基,C 2-8 链烯基等; R 4和R 5各自代表氢,C 1-8烷基等;和 R 6表示氢等;条件是Z和R 3各自连接到苯环上,并且X 2不连接 到苯环)。
-
公开(公告)号:US07119104B2
公开(公告)日:2006-10-10
申请号:US10491935
申请日:2002-10-09
申请人: Shogo Sakuma , Tomio Yamakawa , Takashi Kanda , Seiichiro Masui
发明人: Shogo Sakuma , Tomio Yamakawa , Takashi Kanda , Seiichiro Masui
IPC分类号: C07D413/06 , C07D413/14 , C07D417/06 , A61K31/4178 , A61K31/423 , A61K31/427
CPC分类号: C07D403/06 , A61K31/00 , A61K31/423 , A61K31/427 , A61K31/454 , C07D405/06 , C07D409/06 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/06 , C07D417/12 , C07D417/14
摘要: A compound represented by the formula (I) or a salt of the compound, and a PPAR-δ activator which contains the compound or salt as the active ingredient: (wherein A represents O or S; B1 represents N, etc.; B2 represents O, etc.; each of X1 and X2 represents O, S, a bond, etc.; Y represents C1-8 alkylene chain; Z represents O or S; R1 represents aryl, etc. which can have substituents; R2 represents C1-8 alkyl, etc.; R3 represents C1-8 alkyl, C2-8 alkenyl, etc.; each of R4 and R5 represents hydrogen, C1-8 alkyl, etc.; and R6 represents hydrogen, etc.; provided that each of Z and R3 is attached to the benzene ring, and X2 is not attached to the benzene ring).
摘要翻译: 由式(I)表示的化合物或化合物的盐和含有该化合物或盐作为活性成分的PPAR-δ活化剂:(其中A表示O或S; B < 表示N等; B 2表示O等; X 1和X 2各自表示O,S,键, Y表示C 1-8亚烷基链; Z表示O或S; R 1表示可具有取代基的芳基等; R 2, / SUP表示C 1-8烷基等; R 3表示C 1-8烷基,C 2-8 链烯基等; R 4和R 5各自代表氢,C 1-8烷基等;和 R 6表示氢等;条件是Z和R 3各自连接到苯环上,并且X 2不连接 到苯环)。
-
公开(公告)号:US06787552B2
公开(公告)日:2004-09-07
申请号:US10344496
申请日:2003-02-11
申请人: Shogo Sakuma , Tsuyoshi Endo , Atsushi Tendo , Toshihiro Takahashi , Shinichi Yoshida , Kunio Kobayashi , Nobutaka Mochizuki , Tomio Yamakawa , Takashi Kanda , Seiichiro Masui
发明人: Shogo Sakuma , Tsuyoshi Endo , Atsushi Tendo , Toshihiro Takahashi , Shinichi Yoshida , Kunio Kobayashi , Nobutaka Mochizuki , Tomio Yamakawa , Takashi Kanda , Seiichiro Masui
IPC分类号: A61K31421
CPC分类号: C07D413/04 , C07D263/32 , C07D277/24
摘要: Compounds of the general formula (I) or salts thereof and activators of PPAR&dgr; (peroxisome proliferator activated receptor &dgr;) containing the compounds or the salts as the active ingredient: wherein R1 and R2 each are hydrogen, C1-8 alkyl, an aryl or heterocyclic group which may be substituted, or the like; A is oxygen, sulfur, or the like; X1 and X2 are each a free valency, oxygen, S(O)p (wherein p is an integer of 0 to 2), C(═O), C(═O)NH, NHC(═O), CH═CH, or the like; Y is optionally substituted C1-8 alkylene; Z is oxygen or sulfur; R3 and R4 are each optionally substituted C1-8 alkyl; and R8 is hydrogen or C1-8 alkyl, with the proviso that when X1 is a free valency, X2 is not O or S(O)p, while when X1 is C(═O)NH, X2 is not a free valency.
摘要翻译: 通式(I)的化合物或其盐和含有化合物或其盐作为活性成分的PPARdta(过氧化物酶体增殖物活化受体δ)的活化剂:其中R 1和R 2各自为氢,C 1-8 烷基,可被取代的芳基或杂环基等; A是氧,硫等; X 1和X 2各自为自由价,氧,S(O)p(其中p为0至2的整数),C(= O),C(= O)NH,NHC(= O),CH = CH等; Y是任选取代的C 1-8亚烷基; Z是氧或硫; R 3和R 4各自为任选取代的C 1-8烷基; 并且R 8是氢或C 1-8烷基,条件是当X 1是自由价时,X 2不是O或S(O)p,而当X 1是C(O) = O)NH,X 2不是自由价。
-
公开(公告)号:US5693651A
公开(公告)日:1997-12-02
申请号:US809592
申请日:1997-03-26
申请人: Yutaka Nomura , Shogo Sakuma , Seiichiro Masui
发明人: Yutaka Nomura , Shogo Sakuma , Seiichiro Masui
IPC分类号: A61K31/4709 , A61P3/10 , C07D413/06 , C07D417/06 , C07D417/14 , A61K31/47
CPC分类号: C07D413/06 , C07D417/06 , C07D417/14
摘要: The invention has an object to provide a novel quinoline derivative of the following formula (I) which has no benzyl group in the 5-position and shows hypoglycemic effect, particularly, by oral administration: ##STR1## in which R.sup.1 is hydrogen; an alkyl group of 1-6 carbon atoms, an amino group of the formula of --NR.sup.4 R.sup.5 in which each of R.sup.4 and R.sup.5 independently is hydrogen, alkyl of 1-6 carbon atoms, phenyl, pyridyl, pyrimidyl or benzoyl; or a phenyl group, a naphthyl group, a cycloalkyl group having 3 to 8 carbon atoms, or a 5 to 8 membered heterocyclic group comprising, as ring-constituting atoms, 1 to 2 nitrogens, oxygens or sulfurs and remaining carbon atoms, each of which may have, as a substituent, alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, halogen, hydroxyl, halogenoalkyl of 1-6 carbon atoms, halogenoalkoxy of 1-6 carbon atoms, nitro, amino, phenyl, thienyl, furyl, thiazolyl or pyridyl; Z is O, S, C.dbd.O, or CH.sub.2 ; E is S or O; m is an integer of 0 to 4; p is an integer of 0 to 4; q is an integer of 0 to 4; and the double line composed of a broken line and a solid line means a single or double bond.
摘要翻译: PCT No.PCT / JP95 / 02167 Sec。 371日期1997年3月26日 102(e)1997年3月26日PCT PCT 1995年10月20日PCT公布。 出版物WO96 / 日期:1996年5月2日本发明的目的是提供下述式(I)的喹啉衍生物,其在5-位没有苄基,具有低血糖作用,特别是通过口服给药:
(I) 其中R1是氢; 1-6个碳原子的烷基,-NR4R5的氨基,其R4和R5各自独立地为氢,1-6个碳原子的烷基,苯基,吡啶基,嘧啶基或苯甲酰基; 或苯基,萘基,具有3-8个碳原子的环烷基或5至8元杂环基,其包含作为构成环的原子的1至2个氮,氧或硫和剩余的碳原子 其可以具有1-6个碳原子的烷基,1-6个碳原子的烷氧基,1-6个碳原子的卤素,羟基,卤代烷基,1-6个碳原子的卤代烷氧基,硝基,氨基,苯基, 噻吩基,呋喃基,噻唑基或吡啶基; Z是O,S,C = O或CH 2; E是S或O; m为0〜4的整数。 p为0〜4的整数。 q是0〜4的整数; 由虚线和实线构成的双线表示单键或双键。 -
公开(公告)号:US07652045B2
公开(公告)日:2010-01-26
申请号:US11888493
申请日:2007-07-31
申请人: Shogo Sakuma , Tomio Yamakawa , Takashi Kanda , Seiichiro Masui
发明人: Shogo Sakuma , Tomio Yamakawa , Takashi Kanda , Seiichiro Masui
IPC分类号: A61K31/421 , A61K31/426 , C07D263/30 , C07D277/20
CPC分类号: C07D263/62 , C07D263/32 , C07D277/24
摘要: A compound represented by the following general formula (I): (wherein R1 represents phenyl, etc. which can have substituents selected from the group consisting of C1-8 alkyl, C1-8 alkyl having halogen, halogen, hydroxyl, etc.; R2 represents C1-8 alkyl, etc.; A represents oxygen, sulfur, etc.; X represents C1-8 alkylene chain, etc.; Y represents C(═O), CH═CH, etc.; R3, R4, and R5 each represents hydrogen, C1-8 alkyl, etc.; B represents CH or nitrogen; Z represents oxygen or sulfur; R6 and R7 each represents hydrogen, C1-8 alkyl, etc.; and R8 represents hydrogen or C1-8 alkyl; provided that at least one of R3, R4, and R5 is not hydrogen) or a salt of the compound; and a PPAR-δ activator which contains the compound or salt as the active ingredient.
摘要翻译: 由以下通式(I)表示的化合物:(其中R 1表示可以具有选自C 1-8烷基,具有卤素的C 1-8烷基,卤素,羟基等的取代基的苯基等; R 2 表示C1-8烷基等; A表示氧,硫等; X表示C1-8亚烷基链等; Y表示C(-O),CH-CH等; R3,R4和R5 各自表示氢,C 1-8烷基等; B表示CH或氮; Z表示氧或硫; R6和R7各自表示氢,C1-8烷基等; R8表示氢或C1-8烷基; R3,R4和R5中的至少一个不是氢)或化合物的盐; 和含有该化合物或盐作为活性成分的PPAR-δ活化剂。
-
公开(公告)号:US07648999B2
公开(公告)日:2010-01-19
申请号:US11888492
申请日:2007-07-31
申请人: Shogo Sakuma , Tomio Yamakawa , Takashi Kanda , Seiichiro Masui
发明人: Shogo Sakuma , Tomio Yamakawa , Takashi Kanda , Seiichiro Masui
IPC分类号: A61K31/426 , A61K31/4436 , A61K31/4709 , C07D277/22 , C07D417/04
CPC分类号: C07D263/62 , C07D263/32 , C07D277/24
摘要: A compound represented by the following general formula (I): (wherein R1 represents phenyl, etc. which can have substituents selected from the group consisting of C1-8 alkyl, C1-8 alkyl having halogen, halogen, hydroxyl, etc.; R2 represents C1-8 alkyl, etc.; A represents oxygen, sulfur, etc.; X represents C1-8 alkylene chain, etc.; Y represents C(═O), CH═CH, etc.; R3, R4, and R5 each represents hydrogen, C1-8 alkyl, etc.; B represents CH or nitrogen; Z represents oxygen or sulfur; R6 and R7 each represents hydrogen, C1-8 alkyl, etc.; and R8 represents hydrogen or C1-8 alkyl; provided that at least one of R3, R4, and R5 is not hydrogen) or a salt of the compound; and a PPAR-δ activator which contains the compound or salt as the active ingredient.
摘要翻译: 由以下通式(I)表示的化合物:(其中R 1表示可以具有选自C 1-8烷基,具有卤素的C 1-8烷基,卤素,羟基等的取代基的苯基等; R 2 表示C1-8烷基等; A表示氧,硫等; X表示C1-8亚烷基链等; Y表示C(-O),CH-CH等; R3,R4和R5 各自表示氢,C 1-8烷基等; B表示CH或氮; Z表示氧或硫; R6和R7各自表示氢,C1-8烷基等; R8表示氢或C1-8烷基; R3,R4和R5中的至少一个不是氢)或化合物的盐; 和含有该化合物或盐作为活性成分的PPAR-δ活化剂。
-
8.
公开(公告)号:US20090298896A1
公开(公告)日:2009-12-03
申请号:US12297436
申请日:2007-04-18
申请人: Shogo Sakuma , Nobutaka Mochiduki , Rie Takahashi , Masatoshi Ushioda , Tomio Yamakawa , Seiichiro Masui
发明人: Shogo Sakuma , Nobutaka Mochiduki , Rie Takahashi , Masatoshi Ushioda , Tomio Yamakawa , Seiichiro Masui
IPC分类号: A61K31/426 , C07D277/30 , A61P3/00 , A61P9/10
CPC分类号: C07D277/22 , C07D263/32 , C07D277/20 , C07D277/30 , C07D333/22
摘要: A compound represented by the following general formula (II) or a salt thereof is used as an activator of PPARδ. wherein Ga is O, CH2 or the like; Aa is thiazole, oxazole, or thiophene, which can have a substituent such as C1-8 alkyl, C1-8 alkoxy, halogen, C1-8 alkyl substituted with halogen or the like; Ba is a C1-8 alkylene or C2-8 alkenylene chain; and each of R1a and R2a independently is hydrogen, C1-8 alkyl, C1-8 alkoxy, halogen, C1-8 alkyl substituted with halogen or the like.
摘要翻译: 使用由以下通式(II)表示的化合物或其盐作为PPARδ的活化剂。 其中Ga是O,CH 2等; Aa是噻唑,恶唑或噻吩,其可以具有取代基,例如C 1-8烷基,C 1-8烷氧基,卤素,被卤素取代的C 1-8烷基等; Ba是C 1-8亚烷基或C 2-8亚烯基链; R 1a和R 2a各自独立地为氢,C 1-8烷基,C 1-8烷氧基,卤素,被卤素等取代的C 1-8烷基。
-
9.
公开(公告)号:US20090240058A1
公开(公告)日:2009-09-24
申请号:US11885265
申请日:2006-02-28
申请人: Shogo Sakuma , Tomio Yamakawa , Nobutaka Mochiduki , Seiichiro Masui , Rie Takahashi , Toshitake Hirai
发明人: Shogo Sakuma , Tomio Yamakawa , Nobutaka Mochiduki , Seiichiro Masui , Rie Takahashi , Toshitake Hirai
IPC分类号: C07D401/02 , C07D231/12 , C07D333/24
CPC分类号: C07D231/12 , C07D207/325 , C07D207/333 , C07D231/22 , C07D307/42 , C07D307/46 , C07D333/16 , C07D333/22 , C07D401/04 , C07D405/04 , C07D409/04
摘要: A compound or its salt having the following formula (II) is used as an activator for PPAR δ: in which each of R11 and R13 is a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, an alkoxy group having 1 to 8 carbon atoms, an alkyl group having 1 to 8 carbon atoms and a halogen atom substituent, etc.; R12 is a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, an alkoxy group having 1 to 8 carbon atoms, an alkyl group having 1 to 8 carbon atoms and a halogen atom substituent, etc.; each of R14 and R15 is a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, or an alkyl group having 1 to 8 carbon atoms and a halogen atom substituent; X1 is CH or N; Z1 is an oxygen atom or a sulfur atom; W1 is an oxygen atom or CH2; and q is an integer of 2 to 4.
摘要翻译: 使用具有下式(II)的化合物或其盐作为PPARδ的活化剂:其中R11和R13各自为氢原子,具有1至8个碳原子的烷基,具有1至8个碳原子的烷氧基 碳原子数为1〜8的烷基,卤原子取代基等。 R12为氢原子,碳原子数1〜8的烷基,碳原子数1〜8的烷氧基,碳原子数1〜8的烷基和卤素原子取代基等。 R 14和R 15各自为氢原子,碳原子数1〜8的烷基或碳原子数1〜8的烷基和卤原子取代基。 X1是CH或N; Z1是氧原子或硫原子; W1是氧原子或CH2; q为2〜4的整数。
-
公开(公告)号:US07265137B2
公开(公告)日:2007-09-04
申请号:US10486783
申请日:2002-08-02
申请人: Shogo Sakuma , Tomio Yamakawa , Takashi Kanda , Seiichiro Masui
发明人: Shogo Sakuma , Tomio Yamakawa , Takashi Kanda , Seiichiro Masui
IPC分类号: A61K31/421 , A61K31/426 , C07D213/30 , C07D277/20
CPC分类号: C07D263/62 , C07D263/32 , C07D277/24
摘要: A compound represented by the following general formula (I): (wherein R1 represents phenyl, etc. which can have substituents selected from the group consisting of C1-8 alkyl, C1-8 alkyl having halogen, halogen, hydroxyl, etc.; R2 represents C1-8 alkyl, etc.; A represents oxygen, sulfur, etc.; X represents C1-8 alkylene chain, etc.; Y represents C(═O), CH═CH, etc.; R3, R4, and R5 each represents hydrogen, C1-8 alkyl, etc.; B represents CH or nitrogen; Z represents oxygen or sulfur; R6 and R7 each represents hydrogen, C1-8 alkyl, etc.; and R8 represents hydrogen or C1-8 alkyl; provided that at least one of R3, R4, and R5 is not hydrogen) or a salt of the compound; and a PPAR-δ activator which contains the compound or salt as the active ingredient.
摘要翻译: 由以下通式(I)表示的化合物:(其中R 1表示苯基等,其可以具有选自C 1-8烷基的取代基 具有卤素,卤素,羟基等的C 1-8烷基; R 2表示C 1-8烷基等; A 表示氧,硫等; X表示C 1-8亚烷基链等; Y表示C(-O),CH-CH等; R 3 O R 4,R 5和R 5各自表示氢,C 1-8烷基等; B表示CH或氮; Z表示 氧或硫; R 6和R 7各自表示氢,C 1-8烷基等;和R 8, / SUP>表示氢或C 1-8烷基,条件是R 3,R 4和R 4中的至少一个, 5不是氢)或化合物的盐; 和含有该化合物或盐作为活性成分的PPAR-δ活化剂。
-
-
-
-
-
-
-
-
-